Commonwealth of Pennsylvania Public School Empls Retrmt SYS Makes New Investment in Indivior PLC $INDV

Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new stake in shares of Indivior PLC (NASDAQ:INDV) in the fourth quarter, Holdings Channel reports. The fund acquired 30,910 shares of the company’s stock, valued at approximately $1,109,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Oaktree Capital Management LP increased its position in shares of Indivior by 2,241.6% in the third quarter. Oaktree Capital Management LP now owns 257,785,398 shares of the company’s stock worth $6,215,206,000 after acquiring an additional 246,776,273 shares in the last quarter. Divisadero Street Capital Management LP lifted its position in shares of Indivior by 2,372.5% in the 3rd quarter. Divisadero Street Capital Management LP now owns 3,362,605 shares of the company’s stock valued at $81,072,000 after acquiring an additional 3,226,605 shares in the last quarter. Vanguard Group Inc. boosted its stake in Indivior by 57.9% in the 4th quarter. Vanguard Group Inc. now owns 5,473,891 shares of the company’s stock worth $196,403,000 after purchasing an additional 2,008,078 shares during the period. Goldentree Asset Management LP acquired a new position in Indivior in the 3rd quarter worth approximately $42,630,000. Finally, Newtyn Management LLC grew its position in Indivior by 61.1% during the 3rd quarter. Newtyn Management LLC now owns 4,200,000 shares of the company’s stock worth $101,262,000 after purchasing an additional 1,592,982 shares in the last quarter. 60.33% of the stock is currently owned by institutional investors and hedge funds.

Indivior Price Performance

Shares of Indivior stock opened at $37.39 on Tuesday. The firm has a market cap of $4.56 billion, a price-to-earnings ratio of 19.17 and a beta of 0.88. The stock has a 50-day simple moving average of $34.76 and a 200-day simple moving average of $34.15. Indivior PLC has a 52-week low of $13.42 and a 52-week high of $41.00.

Indivior (NASDAQ:INDV) last issued its quarterly earnings data on Tuesday, March 31st. The company reported $0.96 earnings per share for the quarter. The firm had revenue of $317.00 million for the quarter. Indivior had a net margin of 19.44% and a negative return on equity of 219.26%. As a group, equities research analysts predict that Indivior PLC will post 4.05 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Weiss Ratings downgraded shares of Indivior from a “hold (c+)” rating to a “hold (c)” rating in a research note on Wednesday, May 6th. Zacks Research raised Indivior from a “hold” rating to a “strong-buy” rating in a research note on Monday, March 16th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $39.33.

About Indivior

Indivior plc is a specialty pharmaceutical company dedicated to developing and delivering treatments for addiction and related mental health disorders. The company’s portfolio centers on therapies designed to support individuals dealing with opioid dependence, alcohol use disorder and other behavioral health challenges. Its lead products include Suboxone® (buprenorphine and naloxone) sublingual film and Sublocade® (extended-release buprenorphine) injection, both of which are approved in multiple markets to aid in opioid use disorder management.

Indivior was established in 2014 through a demerger from the pharmaceuticals division of Reckitt Benckiser Group plc, inheriting decades of research and commercial expertise in addiction medicine.